Suppr超能文献

喹诺酮类抗菌剂西他沙星在小鼠体内的光毒性视网膜变性及毒代动力学

Phototoxic retinal degeneration and toxicokinetics of sitafloxacin, a quinolone antibacterial agent, in mice.

作者信息

Shimoda K, Okawara S, Kato M

机构信息

Tokyo R&D Center, Daiichi Pharmaceutical Co., Ltd., Japan.

出版信息

Arch Toxicol. 2001 Sep;75(7):395-9. doi: 10.1007/s002040100263.

Abstract

We examined drug concentrations and the incidence of retinal degeneration in the eyes of albino BALB/c mice after a single intravenous administration of sitafloxacin plus a 4 h period of UVA irradiation. Retinal degeneration was induced at 40 mg/kg or more plus UVA irradiation, and there was little decrease in ocular sitafloxacin concentration under UVA irradiation. We then examined the incidence of retinal degeneration with various periods of UVA irradiation in BALB/c mice given a single intravenous administration of 40 mg/kg sitafloxacin. Retinal degeneration occurred in all the groups receiving UVA irradiation immediately after sitafloxacin administration, whereas no retinal degeneration occurred in the groups receiving UVA irradiation starting 30 min or later after administration. In addition, we examined both the retinal degeneration and auricular inflammation in BALB/c mice given a 7-day repeated administration of sitafloxacin at 1, 3.3 and 10 mg/kg per day, which never induce retinal or auricular change by a single administration. Retinal degeneration was not induced at any dose level, although auricular skin inflammation was augmented by repeated administration. These results suggest that the occurrence of retinal degeneration depends on maximum ocular sitafloxacin concentration during UVA irradiation, whereas the severity of auricular inflammation is directly proportional to the total decrease in area under the drug concentration curve for auricular sitafloxacin under UVA irradiation. This difference between retinal degeneration and auricular inflammation may derive from their respective mechanisms of pathogenesis.

摘要

我们研究了在白化BALB/c小鼠单次静脉注射司帕沙星并进行4小时紫外线A(UVA)照射后,眼部的药物浓度及视网膜变性的发生率。在40mg/kg及以上剂量加UVA照射时可诱导视网膜变性,且在UVA照射下眼部司帕沙星浓度几乎没有下降。然后,我们研究了单次静脉注射40mg/kg司帕沙星的BALB/c小鼠在不同UVA照射时长下视网膜变性的发生率。在司帕沙星给药后立即接受UVA照射的所有组中均发生了视网膜变性,而在给药后30分钟或更晚开始接受UVA照射的组中未发生视网膜变性。此外,我们研究了每天以1、3.3和10mg/kg的剂量对BALB/c小鼠进行7天重复给药司帕沙星后的视网膜变性和耳部炎症情况,单次给药时这些剂量均不会引起视网膜或耳部变化。尽管重复给药会加剧耳部皮肤炎症,但在任何剂量水平下均未诱导视网膜变性。这些结果表明,视网膜变性的发生取决于UVA照射期间眼部司帕沙星的最高浓度,而耳部炎症的严重程度与UVA照射下耳部司帕沙星药物浓度曲线下面积的总下降量成正比。视网膜变性和耳部炎症之间的这种差异可能源于它们各自的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验